Can Cannabis Reduce Dependency on Pharmaceutical Anxiolytics for Anxiety?

PostedFebruary 26, 2026

UpdatedFebruary 26, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Some patients may explore cannabis to replace anxiety medication as a complementary or alternative approach to managing anxiety symptoms. When carefully implemented, it can support tapering off SSRIs, encourage reduced benzodiazepine use, and serve as a viable alternative therapy under professional supervision. Proper dosing and monitoring are essential to ensure safety and maintain therapeutic benefits.

Supporting Medication Reduction

Thoughtful use of cannabis to replace anxiety medication can help patients gradually reduce reliance on traditional anxiolytics, promoting safer and more sustainable anxiety management.

Tapering Off SSRIs

Integrating cannabis may assist in tapering off SSRIs, helping to manage withdrawal symptoms and maintain mood stability during dose adjustments.

Reduced Benzodiazepine Use

Reduced benzodiazepine use can be achieved when cannabis provides calming effects, lowering dependence on sedative medications for anxiety control.

Alternative Therapy

Using cannabis to replace anxiety medication offers an alternative therapy option for patients seeking a more holistic or natural approach to symptom management.

Professional oversight ensures safe integration, optimising outcomes and minimising potential side effects when using cannabis to replace anxiety medication in treatment plans.

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.